Insight Molecular Diagnostics Inc. IMDX
1.66 USD +0.07 (+4.40%)
Regular-session close
1.78 +0.12 +7.23%
After hours · Nov 19, 7:06 PM ET
1.60 Day range 1.80
1.59 52-week range 7.50
- YTD
- -77.87%
- 1 year
- -72.33%
IMDX revenue history
Revenue is income from the company’s ordinary business activities.
4,055,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 4,055,000 | 2,174,000 | 115.58% |
| FY 2024 | 2024-12-31 | 1,881,000 | 378,000 | 25.15% |
| FY 2023 | 2023-12-31 | 1,503,000 | 545,000 | 56.89% |
| FY 2022 | 2022-12-31 | 958,000 | -1,240,000 | -56.41% |
| FY 2021 | 2021-12-31 | 2,198,000 | 982,000 | 80.76% |
| FY 2020 | 2020-12-31 | 1,216,000 | 1,216,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-19T07:00:40.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
